Renowned experts in the Health and Biotechnology sectors of Cuba and the Association of Southeast Asian Nations (ASEAN) today held a videoconference to exchange experiences on confronting and containing COVID -19.

A message of recognition and gratitude to blood donors in Cuba, on World Blood Donor Day, Cuban minister of public health, Jose Angel Portal Miranda, sent today.

The Annual Prize of Immunology Jorge Gavilondo Cowley in Memoriam, was awarded to the research work Design, Development and Preclinical Evaluation of Soberana 02: a Cuban vaccine against COVID-19 in the context of the recent Latin American and Caribbean Congress of Immunology (Alaci-2022).

Fulfilling the surgical demand, emergency care and medical assistance of the Maternal and Infant Care Program is possible in Cuba thanks to voluntary blood donations.

Cuba studied a total of 4,173 samples for surveillance, resulting positive 31 for 0.7% of positivity. The country accumulates 13,904,794 samples taken and 1,105,577 positive (8.0%).

The renowned The Lancet Respiratory Medicine magazine published the successful clinical tests practiced for the Cuban vaccine Soberana Plus, which proved its effectiveness in reinforcing immunity against different variants of SARS-CoV-2.

The system of protected areas in Holguin province has three new spaces approved by the Council of Ministers, as part of the conservation and management programs of the endemic flora and fauna, with more than 500 species in the eastern territory.

A European Union expert in training on actions to tackle climate change pondered in this city what Cuba does to this end and for the benefit of the most vulnerable populations.

A total of 37,434,927 anti-COVID-19 doses have been administered in Cuba, with the vaccines developed in the country, Soberana 02, Soberana Plus and Abdala.

Cuba studied a total of 2,984 samples for surveillance, 13 were positive, for 0.4% of positivity. The country accumulates 13,892,699 samples taken and 1,105,490 positive.

A total of 9,966,330 people have completed the anti-COVID-19 vaccination program in Cuba, with the vaccines developed in the country, Soberana 02, Soberana Plus and Abdala.

Cuba studied a total of 3,322 samples for surveillance, 16 were positive, for 0.5% of positivity. The country accumulates 13,889,715 samples taken and 1,105,477 positive (8.0%).

A total of 7,275,031 people in Cuba have received anti-COVID-19 booster doses, the ministry of public health (MINSAP by its Spanish acronym) reported today.

The low reports of new cases of Covid-19 in Cuba, the 22nd consecutive day without deaths from this disease and the absence of critical or serious patients are elements that confirm the control of Sars-Cov-2 in the country.